Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    zd6126
Show Display Options
Rank Status Study
1 Suspended Exploratory Study to Assess the Biological Activity of ZD6126 in Subjects With Newly Diagnosed Metastatic Renal Cell Carcinoma (Stage IV)
Conditions: Carcinoma, Renal Cell;   Kidney Neoplasms
Interventions: Drug: ZD6126;   Drug: Placebo
2 Terminated Safety, Tolerability and Efficacy of ZD6126 in Combination With Oxaliplatin, 5-Fluorouracil and Leucovorin in Subjects With Metastatic Colorectal Cancer.
Conditions: Colorectal Neoplasms;   Metastases, Neoplasm
Interventions: Drug: ZD6126;   Drug: Placebo;   Drug: 5-fluorouracil;   Drug: leucovorin;   Drug: oxaliplatin

Indicates status has not been verified in more than two years